HCW ( Drg ) Safety Sep2015

7/26/2019 HCW ( Drg ) Safety Sep2015

1/26

CURICULUM VITAECURICULUM VITAE

NAMANAMA : Dr. SH. MANULLANG SpB (K), FICS.: Dr. SH. MANULLANG SpB (K), FICS.

N.I.P.N.I.P. : 195!1!519"#!#1!!1.: 195!1!519"#!#1!!1.

PANGKATPANGKAT : PNS G$%. IV&E.: PNS G$%. IV&E.

TEMPAT'T%. L*+r : BAGANSIAPIAPI, 5 -.195.TEMPAT'T%. L*+r : BAGANSIAPIAPI, 5 -.195.

ALAMATALAMAT : KAPLING PLRI B%$/ F&" -$.159!: KAPLING PLRI B%$/ F&" -$.159!

ELAMBAR&GRGLELAMBAR&GRGL

AKARTA BARAT 0 112!AKARTA BARAT 0 112!

T3%p. (!#1) 524! HP : !"12 ""141.T3%p. (!#1) 524! HP : !"12 ""141.

3&+% :3&+% : && -6%%-7*8*$$.$-6%%-7*8*$$.$

&& -6%%-7*8+%.$-6%%-7*8+%.$

; PRFESI :; PRFESI :

& INFECTIN CNTRL CNSULTANT& INFECTIN CNTRL CNSULTANT& PATIENT SAFET< CNSULTANT& PATIENT SAFET< CNSULTANT

& TRAUMATLG< CNSULTANT& TRAUMATLG< CNSULTANT

& GENERAL SURGEN& GENERAL SURGEN

PENDIDIKAN :PENDIDIKAN :

& DKTER UMUM : FK UKI /r= (1949 ).& DKTER UMUM : FK UKI /r= (1949 ).

& SPESIALIS BEDAH : FK UI /r= (199!).& SPESIALIS BEDAH : FK UI /r= (199!).

& KNSULTAN TRAUMA : ICS&IGSS (#!!9 ).& KNSULTAN TRAUMA : ICS&IGSS (#!!9 ).

; INTERNATINAL & CURSE :; INTERNATINAL & CURSE :

& INFECTIN CNTRL CURSE & S+-p$r3& INFECTIN CNTRL CURSE & S+-p$r3

(#!!)(#!!)

& PATIENT SAFET< CURSE & B67-&K$r3 (#!!")& PATIENT SAFET< CURSE & B67-&K$r3 (#!!")

& INFECTIN CNTRL ADVANCED CURSE && INFECTIN CNTRL ADVANCED CURSE &

S+-p$r3 (#!!")S+-p$r3 (#!!")

& PATIENT SAFET< CURSE & M3%>$6r-3 (#!11)& PATIENT SAFET< CURSE & M3%>$6r-3 (#!11)

& INFECTIN CNTRL ADVANCED CURSE& INFECTIN CNTRL ADVANCED CURSE

S*-*+ & C*+- (#!1).S*-*+ & C*+- (#!1).

PIAGAM PENGHARGAAN : DKTER PUSKESMAS TELADAN 19"2.PIAGAM PENGHARGAAN : DKTER PUSKESMAS TELADAN 19"2.

RI?A


2/26

22

HEALTH CARE WORKER SAFETY( Kesehatan dan Keselamatan Petugas )

Dr. S.H. MANULLANG SpB(K), FICSDIREKTUR PELAYANAN DAN PENUNJANG MEDIK

RSU UKI-JAKARTA

PELATIHAN KEWASPADAANISOLASI TERKAIT HIV-AIDSJAKARTA, -!" SEPTEMBER #"!$

[email protected]


3/26

33

TUJUAN PROGRAM PENCEGAHAN & PENANGGULANGAN

INFEKSI ADALAH MELINDUNGI :

Pasien

P3=67 /373*=- ' HEALTH CARE ?RKER

Pengn!ng " #as$a%aa' sei'a%

TERHADAP INFEKSI

[email protected]


4/26

((

P%&'*+%*%&

P7+3-'

P3-6-6-

=3rp-

P3r%=- ' L+-/6--

[email protected]


5/26

))

PPe'gas ese*a'an +e%isi, 'e%e'gas ese*a'an +e%isi, 'e%''-a% in.esi-a% in.esi

Pe'gas ese*a'an *a%s #en/a0a' 0e-a'i*anPe'gas ese*a'an *a%s #en/a0a' 0e-a'i*an ::

#engenai 0en$ai' in.esi1#engenai 0en$ai' in.esi1

a%a '%ans#isia%a '%ans#isi

'in/aan 0enega*an /an 0engen/a-ian'in/aan 0enega*an /an 0engen/a-ian

Pe%-Pe%- 0%,0%,g%a# Kese*a'an /an Kese-a#a'ang%a# Kese*a'an /an Kese-a#a'an KKe%!ae%!a

P%,g%a# K34P%,g%a# K34

[email protected]


6/26

55

T'' Pr/r0 K1

Meninga'an ea#anan -ingnganMeninga'an ea#anan -ingngan

Me#0e%'a*anan ese*a'anMe#0e%'a*anan ese*a'an 0e'gas0e'gas

Meng%angi +ia$aMeng%angi +ia$a

Menega* 'i#+-n$a 6a+a*Menega* 'i#+-n$a 6a+a*

Menega* 'n''an *#Menega* 'n''an *#

[email protected]


7/26

77

Pr/r0 K%*%&Kr23

Pe#e%isaan ese*a'anPe#e%isaan ese*a'an+e%a-a+e%a-a

Penega*an 0en-a%anPenega*an 0en-a%an in.esi 'e%*a/a0in.esi 'e%*a/a0 0e'gas0e'gas

ese*a'anese*a'anPenPen$e/iaan$e/iaanSa%ana Ke6as0a/aanSa%ana Ke6as0a/aan Is,-asiIs,-asi

Pe#+e%ian i##nisasiPe#+e%ian i##nisasi Te'ans1 He0891 F- 4 Te'ans1 He0891 F- 4

Pena'a-asanaPena'a-asanaaann 0asa0asa -a ai+a'-a ai+a' +en/a 'a!a#+en/a 'a!a#

+eas 0aai+eas 0aai

[email protected]


8/26

P%2%45 SrK%3*p4 S&4r

A-a' Pe-in/ng Di%iA-a' Pe-in/ng Di%i APD4APD4 *a%s 'e%se/ia 0*a%s 'e%se/ia 0

/i/i %ang%ang0e%a6a'an0e%a6a'an/an 'in/aan1/an 'in/aan1

'e%'a#a %angan e#e%gensi'e%'a#a %angan e#e%gensi

In/iasi 0e#aaian /an a%a #e-e0asan APDIn/iasi 0e#aaian /an a%a #e-e0asan APD

*a%s /i0a*a#i /engan +ai*a%s /i0a*a#i /engan +ai

[email protected]


9/26

;;

P%6% p%'7r

58%+*5MMeene%a0anne%a0anKKe6as0a/aane6as0a/aan Is,-asi S'an/a% /anIs,-asi S'an/a% /an9e%/asa%an T%ans#isi49e%/asa%an T%ans#isi4

Men!aga ese*a'Men!aga ese*a'aan sa-%ann sa-%an na0asna0as'i/a #e%,,'i/a #e%,,44

Men!aga ese*a'an '+* sea%a ##Men!aga ese*a'an '+* sea%a ##

MMen!aga e+e%si*anen!aga e+e%si*an/an *igiena/an *igiena/i%i/i%i

Men!aga 0e%i-a *i/0 se*a'Men!aga 0e%i-a *i/0 se*a'

Ti/a #e#ani0-asi !a%# +eas 0aaiTi/a #e#ani0-asi !a%# +eas 0aai

[email protected]


10/26


11/26


12/26


13/26

0en*

99ang sa#0a*ang sa#0a*#e/is#e/is sesai 'e#0a'n$asesai 'e#0a'n$a

Jaga e+e%si*an -ingnganJaga e+e%si*an -ingngan

Jaga -an'ai 'e'a0 e%ing /an 'i/a -iinJaga -an'ai 'e'a0 e%ing /an 'i/a -iin

[email protected]


14/26

+%- 7p3% r* (@%3>$=$+)

6-/- =>6- /6 (vacutainer)

? -- %3=//- - 3-+-%/- r6

/36%+ /3 7@3= >$

[email protected]


15/26


16/26


17/26

3r

P3r+/7 r* HCV, HBV, HIV

S376+ T>3%

[email protected]

T9%7 PPP '&'+


18/26

PERDALIN"2=


19/26


20/26

2=2=

A%6r PPP p p-- HIVK=3$r+ P-- (KP)

Sumber pajanan berupa darah, cairan berdarah, atau bahan lain yang berpotensi

menularkan infeksi (OPIM), atau alat kesehatan yang tercemar dari salah satu bahan

tersebut

OPIMTidak perlu

PPP

arah atau cairan berdarah

!ulit tidak utuh " selaput mukosa

T+/

Macam pajanan yang terjadi

!ulit yang utuh Pajanan perkutan

#olume$ Tak perlu PPPSeberapa berat$

Sedikit(Satu tetes, dalam %aktu

singkat)

&anyak(&eberapa tetes, percikan darah

banyak dan"atau dalam %aktu

lama)

Tidak berat('arum solid atau

goresan superfisial)

ebih berat('arum besar bersaluran,

tusukan dalam, darah terlihat,

jarum bekas pasien)

KP 1 KP # KP # KP


21/26

2


22/26

2222

TATALAKSANA PPP HIV

K=3$r+

P-- (KP)

K=3$r+ S6>3r

p-- (KS HIV)

R3/$3-7+ P3-$>=-

1 1 (r3-*) >= =+/ +-6r/-R+7+/$ =$/7+7+=7 $>= r+ r+7+/$ =3r+-@3/7+HIV

1 # (=+-+) P3r=+>-/- AT TC I-+-+r

P-- 3+%+/+ r+7+/$ - p3r%6+p3r=+>-/-

# 1 (r3-*) D+-6r/- AT TC I-+-+r K3>-/- p-- 76/ %- /=3$r+ +-+

#

#1 =6 #

D+-6r/- AT TC +-+-+r =6 -3%@+-+r

A-6r- p3-$>=- 73% +-6 3--A-6r- p3-$>=- 73% +-6 3-- $7+7$7+7::ATAT: /%+ 73*r+ 8 #!! , =6 # /%+ 73*r+ 8 !!: /%+ 73*r+ 8 #!! , =6 # /%+ 73*r+ 8 !!TCTC: # /%+ 73*r+ 8 15!: # /%+ 73*r+ 8 15!I-+-+rI-+-+r: 73*r+ 8 "!! 1 73>3%6 /- =6 # 73=3%* /- -: 73*r+ 8 "!! 1 73>3%6 /- =6 # 73=3%* /- ->-/ +-6, +3= r3-* %3*>-/ +-6, +3= r3-* %3*

R + 4 5


23/26

2323

R%+/0%4*5p%09%r5 PPP

PAJANAN

SUMBE !"#AK#"KE!A$U"

SUMBEP%S"!"&

SUMBEP%S"!"& "S"K%

!"N''"EJ"MEN

K6%+= 6=6* T+/ p3r%6 PPPT+/ p3r%6PPP

T+/ p3r%6 PPP

M6/$7 '

K6%+= =+/ 6=6*

P3r=+>-/-r3+3- # $>=

B3r+/-r3+3- # $>=

B3r+/- r3+3- #$>=

AT !! TC 15!

' 1# #" *r+

T676/- >3-= S$%+

B3r+/- r3+3- #$>=

B3r+/-r3+3- # $>=

B3r+/- r3+3- $>=

AT !!

TC 15!

L$p'r !!'1!!

' 1# #" *r+T676/- >3-= >3r$-

B3r+/- r3+3- #$>=

B3r+/-r3+3- $>=

B3r+/- r3+3- $>=

[email protected]


24/26

2(2(

RISIKO SEROKONVERSI;

P-- r* ' +r- =6>6* % 6%* >37r

D+=-+ :

L6/ %

Dr* =3r%+*= 3%7

A/+>= =3r=676/ r6

P-- p7+3- % 7=+6 AIDS

[email protected]


25/26

2)2)

MONITORING PPP-HIV

Pr$@+%/7+7 *r67 +>3r+/- #" *r+

D+>6=6*/- 6/6-- p7+/$7$7+%

P33r+/7- %>$r=$r+6 :

3-3=*6+ pr$737 +-@3/7+

3$-+=$r 3@3/ =$/7+/ ARV

T37 HIV +6%- 73=3%* 2 +-6, >6%-, 2 >6%-

[email protected]


26/26

2525

[email protected]

HCW ( Drg ) Safety Sep2015

Documents

Transcript of HCW ( Drg ) Safety Sep2015